When a dog presents with reduced mobility, joint disease is often an immediate consideration. Osteoarthritis, cranial cruciate ligament disease, hip dysplasia, and other orthopedic conditions are common contributors to pain and impaired movement.

But mobility is not determined by the joints alone.

Skeletal muscle is an essential component of the musculoskeletal system, contributing to movement, joint stabilization, postural control, and physical function. When muscle mass declines, a patient can lose strength and functional capacity even when the underlying joint disease is appropriately managed.

This distinction is important because treating joint disease and addressing muscle loss are not interchangeable approaches. They target different aspects of mobility—but they can and should work together.

The Joint and the Muscle: Two Different Clinical Targets

A useful way to approach reduced mobility is to consider two interconnected questions:

What is limiting this patient's ability to move comfortably?

And:

Does this patient have sufficient muscle mass and strength to move effectively?

For many patients, the answer to both questions is yes.

Joint disease can create pain and inflammation that discourage activity. Reduced activity can then contribute to muscle loss. As muscle mass and strength decline, the patient may have less capacity to stabilize joints and perform normal movement.

This can create a cycle:

Joint pain or dysfunction → reduced activity → muscle loss → reduced strength and stability → further mobility impairment

Breaking that cycle requires addressing both the source of discomfort and the loss of functional muscle.

Treating the Joint

The management of canine joint disease is typically multimodal. Treatment is individualized according to the patient's diagnosis, disease stage, pain level, body condition, activity level, and overall health.

Weight Management

Maintaining an appropriate body weight is one of the foundational components of osteoarthritis management. Excess body weight increases mechanical loading on the joints and can contribute to a pro-inflammatory state.

For overweight patients, a carefully managed weight-loss program can reduce the mechanical burden placed on affected joints while supporting overall mobility.

Importantly, weight management should focus on body composition, not simply the number on the scale. Reducing excess fat while preserving lean muscle is particularly important in a patient already experiencing muscle loss.

Pharmacologic Pain Management

Depending on the patient and underlying disease, pharmacologic management may include NSAIDs, anti-nerve growth factor monoclonal antibodies, adjunctive analgesics, and other medications.

The objective is to reduce pain and improve comfort so that the patient can participate more effectively in normal activity and rehabilitation.

Joint-Supportive Nutrition and Supplements

Nutritional strategies may also be incorporated into a multimodal joint-management plan.

Depending on the patient's needs, veterinarians may consider therapeutic diets or nutraceuticals containing ingredients such as omega-3 fatty acids, green-lipped mussel, undenatured type II collagen, glucosamine, or chondroitin. The level of evidence varies among ingredients, so product selection should be based on available evidence, product quality, and the individual patient's needs.

Rehabilitation and Therapeutic Exercise

Controlled exercise and rehabilitation are particularly important because they can help maintain range of motion, strength, endurance, and function while supporting joint health.

Depending on the patient, rehabilitation may include therapeutic exercise, underwater treadmill or swimming, range-of-motion exercises, manual therapy, and other modalities.

This is also where the relationship between joint health and muscle health becomes especially apparent.

Improving joint comfort can make movement possible. Appropriate movement helps maintain muscle.

But what happens when muscle loss has already occurred?

---

Treating Muscle Loss

Muscle loss requires a different therapeutic focus.

A patient can have appropriately managed joint pain and still have inadequate muscle mass to support normal function. This is particularly relevant in senior dogs, patients with chronic orthopedic disease, dogs recovering from surgery or injury, and patients that have experienced prolonged periods of reduced activity.

Therapeutic Exercise and Rehabilitation

Exercise is an important tool for maintaining and rebuilding muscle.

A rehabilitation professional can develop a controlled program based on the patient's diagnosis, physical capabilities, and stage of recovery. Therapeutic exercises can be progressively adjusted to encourage muscle activation and strength without unnecessarily aggravating the underlying orthopedic condition.

For a dog with significant muscle loss, however, rehabilitation is only one component of a comprehensive muscle-health strategy.

Nutritional Support

Adequate nutrition provides the foundation for maintaining lean muscle. Ensuring that a patient's diet provides appropriate calories, amino acids, and other essential nutrients is an important first step.

However, simply increasing dietary protein or calories is not necessarily the same as specifically addressing age- or disease-associated muscle loss.

Muscle health is influenced by the balance between anabolic signals that support muscle maintenance and catabolic signals that promote muscle breakdown.

This is an area in which targeted nutritional support may have a role.

Targeted Muscle Support with Fortetropin

MYOS Canine Muscle Formula provides a targeted nutritional approach to muscle health using Fortetropin®, a proprietary ingredient derived from fertilized egg yolk.

Fortetropin has been investigated for its effects on pathways associated with muscle protein turnover, including myostatin, a regulatory protein involved in limiting skeletal muscle growth.

By supporting an environment favorable to muscle maintenance and development, Fortetropin is intended to complement exercise and rehabilitation strategies in dogs where maintaining or rebuilding lean muscle is a clinical priority.

This makes muscle-focused supplementation fundamentally different from a traditional joint supplement.

Joint supplements are generally selected to support the joint environment. MYOS Canine Muscle Formula is specifically intended to support muscle health.

The two approaches can therefore be complementary rather than competitive.

Why Treating Both Matters

Consider a senior dog with osteoarthritis and noticeable hind-limb muscle loss.

A joint-focused treatment plan may successfully reduce pain and inflammation. The dog may begin walking more comfortably and become more willing to participate in activity.

But if significant muscle loss has occurred, improved comfort does not automatically restore lost muscle mass.

Conversely, a muscle-focused strategy without adequate pain control may have limited impact because a painful patient may be unwilling or unable to exercise effectively.

This is why the joint and the muscle should be viewed as connected but distinct therapeutic targets.

Joint-focused treatment can help:

• Reduce pain and inflammation

• Improve comfort during movement

• Address underlying orthopedic disease

• Support joint function

• Enable greater participation in activity and rehabilitation

Muscle-focused treatment can help:

• Maintain or support lean muscle mass

• Support strength and physical function

• Improve the muscular support surrounding joints

• Help patients maintain functional capacity during aging, injury, recovery, or periods of reduced activity

• Complement rehabilitation and therapeutic exercise

Neither approach replaces the other.

The Goal: A More Complete Approach to Mobility

For decades, mobility conversations in veterinary medicine have understandably centered on the joints. And for patients with osteoarthritis or other orthopedic disease, appropriate joint and pain management remains essential.

But mobility is ultimately a whole-musculoskeletal function.

A dog needs healthy—or appropriately managed—joints to move comfortably. It also needs sufficient muscle mass and strength to generate movement, stabilize the body, and perform everyday activities.

That means a comprehensive mobility plan may include:

Joint management
Pain control, weight management, joint-supportive nutrition, appropriate supplements, and other interventions directed at the underlying orthopedic condition.

Muscle management
Assessment of muscle condition, appropriate nutrition, therapeutic exercise, rehabilitation, and targeted nutritional support when muscle loss is a concern.

Functional management
Controlled activity, environmental modifications, and ongoing assessment of the patient's ability to perform normal activities.

Together, these strategies address more of the factors that determine how well a dog can move.

Look Beyond the Joint

When evaluating a dog with reduced mobility, consider not only the condition of the joints, but also the condition of the muscles supporting them.

A dog with osteoarthritis may need pain management.

A dog with muscle loss may need a muscle-health strategy.

And many dogs need both.

Because mobility isn't just about how well the joints function. It's also about whether the patient has the muscle mass and physical capacity to use them.

A more complete approach to mobility recognizes the importance of treating both sides of the musculoskeletal system: joint health and muscle health.